A detailed history of Arizona State Retirement System transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 36,957 shares of DNLI stock, worth $860,358. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,957
Previous 33,114 11.61%
Holding current value
$860,358
Previous $768,000 40.1%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$20.96 - $31.05 $80,549 - $119,325
3,843 Added 11.61%
36,957 $1.08 Million
Q2 2024

Aug 05, 2024

BUY
$14.96 - $23.22 $40,840 - $63,390
2,730 Added 8.98%
33,114 $768,000
Q1 2024

May 07, 2024

SELL
$15.83 - $23.35 $5,524 - $8,149
-349 Reduced 1.14%
30,384 $623,000
Q4 2023

Jan 24, 2024

SELL
$16.2 - $23.18 $7,257 - $10,384
-448 Reduced 1.44%
30,733 $659,000
Q3 2023

Nov 06, 2023

BUY
$20.63 - $30.17 $9,675 - $14,149
469 Added 1.53%
31,181 $643,000
Q2 2023

Aug 01, 2023

BUY
$23.37 - $32.96 $73,989 - $104,351
3,166 Added 11.49%
30,712 $906,000
Q1 2023

Apr 27, 2023

BUY
$21.91 - $32.67 $69,717 - $103,955
3,182 Added 13.06%
27,546 $634,000
Q4 2022

Feb 07, 2023

BUY
$26.28 - $33.92 $25,649 - $33,105
976 Added 4.17%
24,364 $677,000
Q3 2022

Nov 07, 2022

BUY
$25.97 - $38.53 $5,739 - $8,515
221 Added 0.95%
23,388 $718,000
Q2 2022

Jul 28, 2022

BUY
$20.88 - $35.19 $35,683 - $60,139
1,709 Added 7.96%
23,167 $682,000
Q1 2022

May 04, 2022

BUY
$29.0 - $47.27 $5,162 - $8,414
178 Added 0.84%
21,458 $690,000
Q4 2021

Feb 04, 2022

SELL
$42.59 - $55.02 $7,581 - $9,793
-178 Reduced 0.83%
21,280 $949,000
Q3 2021

Nov 12, 2021

BUY
$48.48 - $78.23 $13,089 - $21,122
270 Added 1.27%
21,458 $1.08 Million
Q2 2021

Aug 02, 2021

SELL
$50.3 - $78.44 $75,550 - $117,816
-1,502 Reduced 6.62%
21,188 $1.66 Million
Q1 2021

May 06, 2021

BUY
$53.8 - $81.53 $14,526 - $22,013
270 Added 1.2%
22,690 $1.3 Million
Q4 2020

Jan 28, 2021

SELL
$36.89 - $93.56 $54,744 - $138,843
-1,484 Reduced 6.21%
22,420 $1.88 Million
Q3 2020

Nov 05, 2020

BUY
$23.13 - $38.84 $140,121 - $235,292
6,058 Added 33.95%
23,904 $856,000
Q2 2020

Aug 04, 2020

BUY
$16.01 - $28.82 $51,103 - $91,993
3,192 Added 21.78%
17,846 $432,000
Q1 2020

May 05, 2020

BUY
$14.2 - $27.98 $208,086 - $410,018
14,654 New
14,654 $257,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.12B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.